{"count": 8, "results": [{"_id": "34075013", "pmid": 34075013, "pmcid": "PMC8183305", "title": "Symptomatic Hypoglycemia During Treatment with a Therapeutic Dose of Metformin", "journal": "Am J Case Rep", "authors": ["Joseph CMC"], "date": "2021-06-02T00:00:00Z", "doi": "10.12659/AJCR.931311", "meta_date_publication": "2021 Jun 2", "meta_volume": "22", "meta_issue": "", "meta_pages": "e931311", "score": 50257.566, "text_hl": "Within 2 weeks of discontinuing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, there were no further \"attacks\", and the chronic @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@daytime fatigue@@@ and @<m>DISEASE_Disorders_of_Excessive_Somnolence</m> @DISEASE_MESH:D006970 @@@somnolence@@@ significantly improved.", "citations": {"NLM": "Joseph CMC. Symptomatic Hypoglycemia During Treatment with a Therapeutic Dose of Metformin Am J Case Rep. 2021 Jun 2;22():e931311. PMID: 34075013", "BibTeX": "@article{34075013, title={Symptomatic Hypoglycemia During Treatment with a Therapeutic Dose of Metformin}, author={Joseph CMC}, journal={Am J Case Rep}, volume={22}, pages={e931311}}"}}, {"_id": "32467546", "pmid": 32467546, "title": "Bioequivalence and pharmacokinetic comparison of two fixed dose combination of Metformin/ Glibenclamide formulations in healthy subjects under fed condition.", "journal": "Med J Malaysia", "authors": ["Chang CT", "Ang JY", "Wong JM", "Tan SS", "Chin SK", "Lim AB", "Tan WH", "Yuen KH"], "date": "2020-05-01T00:00:00Z", "meta_date_publication": "2020 May", "meta_volume": "75", "meta_issue": "3", "meta_pages": "286-291", "score": 50246.793, "text_hl": "Bioequivalence and pharmacokinetic comparison of two fixed dose combination of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@/ @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@Glibenclamide@@@ formulations in healthy subjects under fed condition.", "citations": {"NLM": "Chang CT, Ang JY, Wong JM, Tan SS, Chin SK, Lim AB, Tan WH, Yuen KH. Bioequivalence and pharmacokinetic comparison of two fixed dose combination of Metformin/ Glibenclamide formulations in healthy subjects under fed condition. Med J Malaysia. 2020 May;75(3):286-291. PMID: 32467546", "BibTeX": "@article{32467546, title={Bioequivalence and pharmacokinetic comparison of two fixed dose combination of Metformin/ Glibenclamide formulations in healthy subjects under fed condition.}, author={Chang CT and Ang JY and Wong JM and Tan SS and Chin SK and Lim AB and Tan WH and Yuen KH}, journal={Med J Malaysia}, volume={75}, number={3}, pages={286-291}}"}}, {"_id": "27068362", "pmid": 27068362, "title": "Using continuous glucose monitoring to assess contributions of premeal and postmeal glucose levels in diabetic patients treated with metformin alone.", "journal": "Diabetes Metab", "authors": ["Lin SD", "Su SL", "Wang SY", "Tu ST", "Hsu SR"], "date": "2016-11-01T00:00:00Z", "doi": "10.1016/j.diabet.2016.03.002", "meta_date_publication": "2016 Nov", "meta_volume": "42", "meta_issue": "5", "meta_pages": "336-341", "score": 50061.67, "text_hl": "For HbA1c levels >=7.7%, add-on therapy to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ should preferentially target control of @<m>DISEASE_Disorders_of_Excessive_Somnolence</m> @DISEASE_MESH:D006970 @@@BEG@@@, whereas targeting both @<m>DISEASE_Disorders_of_Excessive_Somnolence</m> @DISEASE_MESH:D006970 @@@BEG@@@ and @<m>DISEASE_Disorders_of_Excessive_Somnolence</m> @DISEASE_MESH:D006970 @@@PEG@@@ could be of equivalent importance with lower HbA1c levels.", "citations": {"NLM": "Lin SD, Su SL, Wang SY, Tu ST, Hsu SR. Using continuous glucose monitoring to assess contributions of premeal and postmeal glucose levels in diabetic patients treated with metformin alone. Diabetes Metab. 2016 Nov;42(5):336-341. PMID: 27068362", "BibTeX": "@article{27068362, title={Using continuous glucose monitoring to assess contributions of premeal and postmeal glucose levels in diabetic patients treated with metformin alone.}, author={Lin SD and Su SL and Wang SY and Tu ST and Hsu SR}, journal={Diabetes Metab}, volume={42}, number={5}, pages={336-341}}"}}, {"_id": "29870029", "pmid": 29870029, "title": "Metformin added to intensive insulin therapy improves metabolic control in patients with type 1 diabetes and excess body fat.", "journal": "Pol Arch Intern Med", "authors": ["Zawada A", "Naskręt D", "Burchardt P", "Niedźwiecki P", "Piłaciński S", "Wierusz-Wysocka B", "Grzymisławski M", "Zozulińska-Ziółkiewicz D"], "date": "2018-05-30T00:00:00Z", "doi": "10.20452/pamw.4241", "meta_date_publication": "2018 May 30", "meta_volume": "128", "meta_issue": "5", "meta_pages": "294-300", "score": 50061.14, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ added to intensive @GENE_INS @GENE_3630 @@@insulin@@@ therapy improves metabolic control in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@type 1 diabetes@@@ and @<m>DISEASE_Disorders_of_Excessive_Somnolence</m> @DISEASE_MESH:D006970 @@@excess body@@@ fat.", "citations": {"NLM": "Zawada A, Naskręt D, Burchardt P, Niedźwiecki P, Piłaciński S, Wierusz-Wysocka B, Grzymisławski M, Zozulińska-Ziółkiewicz D. Metformin added to intensive insulin therapy improves metabolic control in patients with type 1 diabetes and excess body fat. Pol Arch Intern Med. 2018 May 30;128(5):294-300. PMID: 29870029", "BibTeX": "@article{29870029, title={Metformin added to intensive insulin therapy improves metabolic control in patients with type 1 diabetes and excess body fat.}, author={Zawada A and Naskręt D and Burchardt P and Niedźwiecki P and Piłaciński S and Wierusz-Wysocka B and Grzymisławski M and Zozulińska-Ziółkiewicz D}, journal={Pol Arch Intern Med}, volume={128}, number={5}, pages={294-300}}"}}, {"_id": "12126190", "pmid": 12126190, "title": "Clearance of metformin by hemofiltration in overdose.", "journal": "J Toxicol Clin Toxicol", "authors": ["Barrueto F", "Meggs WJ", "Barchman MJ"], "date": "2002-01-01T00:00:00Z", "doi": "10.1081/clt-120004407", "meta_date_publication": "2002", "meta_volume": "40", "meta_issue": "2", "meta_pages": "177-80", "score": 50055.848, "text_hl": "Clearance of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ by hemofiltration in @DISEASE_Drug_Overdose @DISEASE_MESH:D062787 @@@overdose@@@.", "citations": {"NLM": "Barrueto F, Meggs WJ, Barchman MJ. Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol. 2002;40(2):177-80. PMID: 12126190", "BibTeX": "@article{12126190, title={Clearance of metformin by hemofiltration in overdose.}, author={Barrueto F and Meggs WJ and Barchman MJ}, journal={J Toxicol Clin Toxicol}, volume={40}, number={2}, pages={177-80}}"}}, {"_id": "25256878", "pmid": 25256878, "title": "Effect of metformin on sleep disorders in adolescent girls with polycystic ovarian syndrome.", "journal": "J Pediatr Adolesc Gynecol", "authors": ["El-Sharkawy AA", "Abdelmotaleb GS", "Aly MK", "Kabel AM"], "date": "2014-12-01T00:00:00Z", "doi": "10.1016/j.jpag.2014.01.004", "meta_date_publication": "2014 Dec", "meta_volume": "27", "meta_issue": "6", "meta_pages": "347-52", "score": 50049.324, "text_hl": "CONCLUSION: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ can reduce the incidence of @DISEASE_Sleep_Wake_Disorders @DISEASE_MESH:D012893 @@@sleep disorders@@@ and @<m>DISEASE_Disorders_of_Excessive_Somnolence</m> @DISEASE_MESH:D006970 @@@excessive daytime sleepiness@@@ in adolescent girls with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@.", "citations": {"NLM": "El-Sharkawy AA, Abdelmotaleb GS, Aly MK, Kabel AM. Effect of metformin on sleep disorders in adolescent girls with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol. 2014 Dec;27(6):347-52. PMID: 25256878", "BibTeX": "@article{25256878, title={Effect of metformin on sleep disorders in adolescent girls with polycystic ovarian syndrome.}, author={El-Sharkawy AA and Abdelmotaleb GS and Aly MK and Kabel AM}, journal={J Pediatr Adolesc Gynecol}, volume={27}, number={6}, pages={347-52}}"}}, {"_id": "16750454", "pmid": 16750454, "title": "Metformin-associated lactic acidosis treated with continuous renal replacement therapy.", "journal": "Clin Ther", "authors": ["Alivanis P", "Giannikouris I", "Paliuras C", "Arvanitis A", "Volanaki M", "Zervos A"], "date": "2006-03-01T00:00:00Z", "doi": "10.1016/j.clinthera.2006.03.004", "meta_date_publication": "2006 Mar", "meta_volume": "28", "meta_issue": "3", "meta_pages": "396-400", "score": 50046.39, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-associated @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@ treated with continuous renal replacement therapy.", "citations": {"NLM": "Alivanis P, Giannikouris I, Paliuras C, Arvanitis A, Volanaki M, Zervos A. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther. 2006 Mar;28(3):396-400. PMID: 16750454", "BibTeX": "@article{16750454, title={Metformin-associated lactic acidosis treated with continuous renal replacement therapy.}, author={Alivanis P and Giannikouris I and Paliuras C and Arvanitis A and Volanaki M and Zervos A}, journal={Clin Ther}, volume={28}, number={3}, pages={396-400}}"}}, {"_id": "18726694", "pmid": 18726694, "title": "Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism.", "journal": "Rev Endocr Metab Disord", "authors": ["Ibáñez L", "Díaz R", "López-Bermejo A", "Marcos MV"], "date": "2009-03-01T00:00:00Z", "doi": "10.1007/s11154-008-9096-y", "meta_date_publication": "2009 Mar", "meta_volume": "10", "meta_issue": "1", "meta_pages": "63-76", "score": 50042.438, "text_hl": "In these @SPECIES_9606 @@@girls@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy may reverse the progression to clinical @DISEASE_Ovarian_Diseases @DISEASE_MESH:D010049 @@@ovarian hyperandrogenism@@@, normalize body composition and @<m>DISEASE_Disorders_of_Excessive_Somnolence</m> @DISEASE_MESH:D006970 @@@excess@@@ visceral fat, and delay pubertal progression without attenuating linear growth and bone mineralization, suggesting that adult height may be improved. ", "citations": {"NLM": "Ibáñez L, Díaz R, López-Bermejo A, Marcos MV. Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism. Rev Endocr Metab Disord. 2009 Mar;10(1):63-76. PMID: 18726694", "BibTeX": "@article{18726694, title={Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism.}, author={Ibáñez L and Díaz R and López-Bermejo A and Marcos MV}, journal={Rev Endocr Metab Disord}, volume={10}, number={1}, pages={63-76}}"}}]}